Introducing a New Approach to Clinical Trial Recruitment & Engagement
Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial.
Topics: TrialCentralNet, Decentralized Clinical Trials, Decentralized Solutions, Hybrid Clinical Trials, Hybrid, TCN
Pharma15 Live!
Facilitating the Journey from Patient to Study Participant
The Impact of Dynamic Referral Processing
Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process.
"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."
-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide
Topics: Pharma15 Live!, Call Centers, Matt Kibby, Aaron Fleishman, Hybrid Clinical Trials, Dynamic Referral Processing, Secondary Prescreening
New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.
Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial models to hybrid models with confidence.
Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials
The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.
Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball
New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.
When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.
Topics: Patient Engagement, Study Voices, Surveys, Diversity, Inclusion, Patients, Hybrid Clinical Trials, Whitepaper
Catch Up on Our Content for Clinical Trial Sponsors
Now is the perfect time to catch up on our most popular content of 2021!
Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial enrollment and engagement landscape.
Topics: RSG Arrive, Diversity, Inclusion, Decentralized Clinical Trials, Lookbook, Creative Portfolio
The One Thing Every Sponsor Needs to Start a Decentralized Clinical Trial Off Right
I recently sat down with Chief Innovation Officer Rob Laurens to discuss how BBK's Engagement Solution Center solves many of the challenges sponsors face when planning and initiating a decentralized clinical trial.
Topics: Rob Laurens, Engagement Solution Center, Decentralized Clinical Trials, Focus 5, Decentralized Solutions
Earlier this week, Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, announced its partnership with BBK to provide concierge services for patients participating in its clinical studies. The services are designed to improve patients' and their caregivers' access to high-quality care and innovative treatments for their cancer.
Topics: Most Viewed, Concierge Services, Cellectar
Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the RSG® Arrive travel program and its recent milestone of 20,000 completed trips.
In this in-depth interview, Mike discusses what sets this program apart from others as he highlights the concierge specialists who are experienced in understanding all the ramifications of a request, as it relates not only to arranging a travel itinerary but also ensuring the itinerary supports patient health, safety, and compliance. In addition, Mike shares insight into the significance of the milestone for BBK as well as the industry at large. Click here to read the full article.
Topics: Patient Engagement, Patient Centricity, Patient Travel, Most Viewed, RSG Arrive, Mike Johnson, Outsourcing-Pharma, Engagement Solution Center, Concierge Services
Getting Decentralized Right
What Matters to Patients
In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.
If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.
Topics: Patient, Pharma15 Live!, Most Viewed, Patient Voice, Patient Centric, Decentralized Clinical Trials, Phil Kelly